Senior Lecturer, Research Associate

Our research involves searching for new treatments and detection methods for CNS diseases, like frontotemporal dementia, amyotrophic lateral sclerosis, autism spectrum disorder and disorders involving neuroinflammation. We use techniques such as tissue culture, iPSCs, transfection, cellular assays, immunohistochemistry, radioligand binding, PCR, sequencing and western blots to find new drug targets and therapeutics for these diseases.

MedChem Australia and Associate Lecturer in Chemistry

Andrew completed his PhD under the supervision of Prof. Danielle Skropeta and Prof. Haibo Yu at the University of Wollongong in 2019. Later that year, he joined Michael's research group as a Centre for Drug Discovery Innovation Postdoctoral Fellow (2019-2024). As part of this fellowship Andrew's research focussed on small molecule synthesis and computational studies for a variety of CNS drug discovery projects.  Andrew is currently an Associate Lecturer in the University of Sydney's School of Chemistry (2023-prsent) and a Postdoctoral Fellow with MedChem Australia (2025-present).

Industry affiliated Postdoctoral Researcher

Wendy was awarded a PhD in organic chemistry from the University of Sydney in 2021. Her research was focused on the design and synthesis of bioactive natural products and derivatives as novel anti infectives. At Kinoxis, Wendy strives to develop the first selective small molecule PET tracer for the oxytocin receptor which will be instrumental for further development of the Kinoxis pipeline.

Industry affiliated Postdoctoral Researcher

Post-doctoral Fellow

Sasha majored in Pharmacology while completing her Bachelor of Medical Science at USYD. This exposure made her realise her passion for Pharmacology – specifically the drug design aspect – and led her to approach Prof Michael Kassiou with interest in an Honours project under his supervision. Her Honours project focused on drug design for targeting the oxytocin signalling pathway as an avenue for therapeutics to treat social disorders. This opportunity allowed her to experience working in a lab-based research environment with some of the most gifted people she knows. Sasha enjoyed this process immensely, thus deciding to further pursue this career path by beginning her PhD under the supervision of Dr Eryn Werry and Prof Michael Kassiou, with a focus on drug design in neurodegeneration. She completed her PhD 

Postdoctoral Research Fellow (MedChem Australia)

Associate Lecturer (Teaching and Research) Sydney Pharmacy School

Associate Lecturer (Teaching and Research) Sydney Pharmacy School